These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10180735)

  • 1. Comparisons between inhaled fine particle fractions and lung dose for nebulized aerosols.
    Finlay WH; Stapleton KW; Zuberbuhler P
    J Aerosol Med; 1998; 11 Suppl 1():S65-72. PubMed ID: 10180735
    [No Abstract]   [Full Text] [Related]  

  • 2. Can in vitro particle size measurements be used to predict pulmonary deposition of aerosol from inhalers?
    Thiel CG
    J Aerosol Med; 1998; 11 Suppl 1():S43-52. PubMed ID: 10180732
    [No Abstract]   [Full Text] [Related]  

  • 3. An investigation of nebulized bronchodilator delivery using a pediatric lung model of spontaneous breathing.
    Restrepo RD; Dickson SK; Rau JL; Gardenhire DS
    Respir Care; 2006 Jan; 51(1):56-61. PubMed ID: 16381619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How well do in vitro particle size measurements predict drug delivery in vivo?
    Newman SP
    J Aerosol Med; 1998; 11 Suppl 1():S97-104. PubMed ID: 10180741
    [No Abstract]   [Full Text] [Related]  

  • 5. The current laboratory determination of "respirable mass" is not clinically relevant.
    Newhouse MT
    J Aerosol Med; 1998; 11 Suppl 1():S122-32. PubMed ID: 10180724
    [No Abstract]   [Full Text] [Related]  

  • 6. What is a respirable dose?
    Van Oort M; Truman K
    J Aerosol Med; 1998; 11 Suppl 1():S89-96. PubMed ID: 10180739
    [No Abstract]   [Full Text] [Related]  

  • 7. Discrepancy between in vitro and in vivo dose variability for a pressurized metered dose inhaler and a dry powder inhaler.
    Borgström L; Asking L; Beckman O; Bondesson E; Källén A; Olsson B
    J Aerosol Med; 1998; 11 Suppl 1():S59-64. PubMed ID: 10180734
    [No Abstract]   [Full Text] [Related]  

  • 8. MRI measurement of regional lung deposition in mice exposed nose-only to nebulized superparamagnetic iron oxide nanoparticles.
    Martin AR; Thompson RB; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2008 Dec; 21(4):335-42. PubMed ID: 18800881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of realistic airflow rate on aerosol generation by nebulizers.
    Vecellio L; Kippax P; Rouquette S; Diot P
    Int J Pharm; 2009 Apr; 371(1-2):99-105. PubMed ID: 19150494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of systemic diseases by inhalation of biomolecule aerosols.
    Siekmeier R; Scheuch G
    J Physiol Pharmacol; 2009 Nov; 60 Suppl 5():15-26. PubMed ID: 20134033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioengineering of therapeutic aerosols.
    Edwards DA; Dunbar C
    Annu Rev Biomed Eng; 2002; 4():93-107. PubMed ID: 12117752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aerosol drug delivery: developments in device design and clinical use.
    Rottier B; Grasmeijer F; Hagedoorn P; de Boer AH
    Lancet; 2011 Sep; 378(9795):981-2; author reply 982. PubMed ID: 21907858
    [No Abstract]   [Full Text] [Related]  

  • 13. Smart nebulizers.
    Smaldone GC
    Respir Care; 2002 Dec; 47(12):1434-41; discussion 1441-4. PubMed ID: 12467501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Devices for Improved Delivery of Nebulized Pharmaceutical Aerosols to the Lungs.
    Longest W; Spence B; Hindle M
    J Aerosol Med Pulm Drug Deliv; 2019 Oct; 32(5):317-339. PubMed ID: 31287369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and testing of aerosol delivery systems for reproducible clinical performance.
    Cipolla DC; Farr SJ; Gonda I; Herst CV; Lee RY; Lloyd P; McKinley G; Rubsamen R; Schuster J; Zellhoefer C
    J Aerosol Med; 1998; 11 Suppl 1():S84-8. PubMed ID: 10180738
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhalation therapy of the future--how will it change the way we treat asthma?
    Lötvall J
    J Aerosol Med; 2001; 14 Suppl 1():S45-50. PubMed ID: 11424893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New liquid aerosol generation devices: systems that force pressurized liquids through nozzles.
    Geller DE
    Respir Care; 2002 Dec; 47(12):1392-404; discussion 1404-5. PubMed ID: 12467498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of single versus multiple actuations on the particle size distribution of beclometasone dipropionate metered-dose inhalers.
    Feddah MR; Davies NM
    J Pharm Pharmacol; 2003 Aug; 55(8):1055-61. PubMed ID: 12956894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug delivery devices: issues in drug development.
    Byron PR
    Proc Am Thorac Soc; 2004; 1(4):321-8. PubMed ID: 16113453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guiding aerosol deposition in the lung.
    Coates AL
    N Engl J Med; 2008 Jan; 358(3):304-5. PubMed ID: 18199871
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.